WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Neurolucida
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (113)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.-F.
Right arrow Articles by Schwarzschild, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.-F.
Right arrow Articles by Schwarzschild, M. A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 1, 1999, 19(21):9192-9200

A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice

Jiang-Fan Chen1, Zhihong Huang2, Jianya Ma2, JinMin Zhu2, Rosario Moratalla3, David Standaert3, Michael A. Moskowitz2, J. Stephen Fink1, and Michael A. Schwarzschild1

1 Molecular Neurobiology Laboratory, 2 Stroke and Neurovascular Regulation Laboratory, and 3 Neurology Research Laboratory, Department of Neurology and Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114

Extracellular adenosine critically modulates ischemic brain injury, at least in part through activation of the A1 adenosine receptor. However, the role played by the A2A receptor has been obscured by intrinsic limitations of A2A adenosinergic agents. To overcome these pharmacological limitations, we explored the consequences of deleting the A2A adenosine receptor on brain damage after transient focal ischemia. Cerebral morphology, as well as vascular and physiological measures (before, during, and after ischemia) did not differ between A2A receptor knock-out and wild-type littermates. The volume of cerebral infarction, as well as the associated neurological deficit induced by transient filament occlusion of the middle cerebral artery, were significantly attenuated in A2A receptor knock-out mice. This neuroprotective phenotype of A2A receptor-deficient mice was observed in different genetic backgrounds, confirming A2A receptor disruption as its cause. Together with complimentary pharmacological studies, these data suggest that A2A receptors play a prominent role in the development of ischemic injury within brain and demonstrate the potential for anatomical and functional neuroprotection against stroke by A2A receptor antagonists.

Key words: A2A adenosine receptor; ischemia; stroke; purine receptor; knock-out; neuroprotection


Copyright © 1999 Society for Neuroscience  0270-6474/99/19219192-09$05.00/0


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Roseti, K. Martinello, S. Fucile, V. Piccari, A. Mascia, G. Di Gennaro, P. P. Quarato, M. Manfredi, V. Esposito, G. Cantore, et al.
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors
PNAS, September 30, 2008; 105(39): 15118 - 15123.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. H. Mills, L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
PNAS, July 8, 2008; 105(27): 9325 - 9330.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Takedachi, D. Qu, Y. Ebisuno, H. Oohara, M. L. Joachims, S. T. McGee, E. Maeda, R. P. McEver, T. Tanaka, M. Miyasaka, et al.
CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
J. Immunol., May 1, 2008; 180(9): 6288 - 6296.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. E. Garcia, L. D. Truong, P. Li, P. Zhang, J. Du, J.-F. Chen, and L. Feng
Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis
FASEB J, February 1, 2008; 22(2): 445 - 454.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Mohsenin, T. Mi, Y. Xia, R. E. Kellems, J.-F. Chen, and M. R. Blackburn
Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L753 - L761.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Huang, L. I. Cardenas-Navia, C. C. Caldwell, T. J. Plumb, C. G. Radu, P. N. Rocha, T. Wilder, J. S. Bromberg, B. N. Cronstein, M. Sitkovsky, et al.
Requirements for T Lymphocyte Migration in Explanted Lymph Nodes
J. Immunol., June 15, 2007; 178(12): 7747 - 7755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Haschemi, O. Wagner, R. Marculescu, B. Wegiel, S. C. Robson, N. Gagliani, D. Gallo, J.-F. Chen, F. H. Bach, and L. E. Otterbein
Cross-Regulation of Carbon Monoxide and the Adenosine A2a Receptor in Macrophages
J. Immunol., May 1, 2007; 178(9): 5921 - 5929.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. P. Sevigny, L. Li, A. S. Awad, L. Huang, M. McDuffie, J. Linden, P. I. Lobo, and M. D. Okusa
Activation of Adenosine 2A Receptors Attenuates Allograft Rejection and Alloantigen Recognition
J. Immunol., April 1, 2007; 178(7): 4240 - 4249.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. M. Lappas, Y.-J. Day, M. A. Marshall, V. H. Engelhard, and J. Linden
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation
J. Exp. Med., November 27, 2006; 203(12): 2639 - 2648.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q.-Y. Huang, C. Wei, L. Yu, J. E. Coelho, H.-Y. Shen, A. Kalda, J. Linden, and J.-F. Chen
Adenosine A2A Receptors in Bone Marrow-Derived Cells But Not in Forebrain Neurons Are Important Contributors to 3-Nitropropionic Acid-Induced Striatal Damage as Revealed by Cell-Type-Selective Inactivation.
J. Neurosci., November 1, 2006; 26(44): 11371 - 11378.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. T. Lee, M. Kim, J. D. Joo, G. Gallos, J.-F. Chen, and C. W. Emala
A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R959 - R969.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. Raiteri
Functional pharmacology in human brain.
Pharmacol. Rev., June 1, 2006; 58(2): 162 - 193.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. S. Awad, L. Huang, H. Ye, E. T. A. Duong, W. K. Bolton, J. Linden, and M. D. Okusa
Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy
Am J Physiol Renal Physiol, April 1, 2006; 290(4): F828 - F837.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-J. Day, L. Huang, H. Ye, L. Li, J. Linden, and M. D. Okusa
Renal Ischemia-Reperfusion Injury and Adenosine 2A Receptor-Mediated Tissue Protection: The Role of CD4+ T Cells and IFN-{gamma}.
J. Immunol., March 1, 2006; 176(5): 3108 - 3114.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Lee, J. C. Jen, H. Wang, Z. Chen, H. Mamsa, C. Sabatti, R. W. Baloh, and S. F. Nelson
A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity
Hum. Mol. Genet., January 15, 2006; 15(2): 251 - 258.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. I. Tikh, R. A. Fenton, and J. G. Dobson Jr.
Contractile effects of adenosine A1 and A2A receptors in isolated murine hearts
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H348 - H356.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Kachroo, L. R. Orlando, D. K. Grandy, J.-F. Chen, A. B. Young, and M. A. Schwarzschild
Interactions between Metabotropic Glutamate 5 and Adenosine A2A Receptors in Normal and Parkinsonian Mice
J. Neurosci., November 9, 2005; 25(45): 10414 - 10419.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
L. Yu, P. M. Haverty, J. Mariani, Y. Wang, H.-Y. Shen, M. A. Schwarzschild, Z. Weng, and J.-F. Chen
Genetic and pharmacological inactivation of adenosine A2A receptor reveals an Egr-2-mediated transcriptional regulatory network in the mouse striatum
Physiol Genomics, September 21, 2005; 23(1): 89 - 102.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-J. Day, Y. Li, J. M. Rieger, S. I. Ramos, M. D. Okusa, and J. Linden
A2A Adenosine Receptors on Bone Marrow-Derived Cells Protect Liver from Ischemia-Reperfusion Injury
J. Immunol., April 15, 2005; 174(8): 5040 - 5046.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y.-J. Day, L. Huang, H. Ye, J. Linden, and M. D. Okusa
Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F722 - F731.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Lappas, J. M. Rieger, and J. Linden
A2A Adenosine Receptor Induction Inhibits IFN-{gamma} Production in Murine CD4+ T Cells
J. Immunol., January 15, 2005; 174(2): 1073 - 1080.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. B. Reiss, M. M. Rahman, E. S. L. Chan, M. C. Montesinos, N. W. Awadallah, and B. N. Cronstein
Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages
J. Leukoc. Biol., September 1, 2004; 76(3): 727 - 734.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lukashev, A. Ohta, S. Apasov, J.-F. Chen, and M. Sitkovsky
Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the Gs Protein-Coupled A2A Adenosine Receptor In Vivo
J. Immunol., July 1, 2004; 173(1): 21 - 24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y.-J. Day, M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden
Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction
Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G285 - G293.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Gomez and M. V. Sitkovsky
Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo
Blood, December 15, 2003; 102(13): 4472 - 4478.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S.N. Schiffmann, D. Dassesse, P. d'Alcantara, C. Ledent, S. Swillens, and M. Zoli
A2A receptor and striatal cellular functions: Regulation of gene expression, currents, and synaptic transmission
Neurology, December 9, 2003; 61(90116): S24 - 29.
[Abstract] [Full Text]


Home page
NeurologyHome page
M. A. Schwarzschild, K. Xu, E. Oztas, J. P. Petzer, K. Castagnoli, N. Castagnoli Jr., and J.-F. Chen
Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease
Neurology, December 9, 2003; 61(90116): S55 - 61.
[Abstract] [Full Text]


Home page
NeurologyHome page
P. Popoli, C. Frank, M.T. Tebano, R.L. Potenza, A. Pintor, M.R. Domenici, V. Nazzicone, A. Pezzola, and R. Reggio
Modulation of glutamate release and excitotoxicity by adenosine A2A receptors
Neurology, December 9, 2003; 61(90116): S69 - 71.
[Abstract] [Full Text]


Home page
NeurologyHome page
M. El Yacoubi, J. Costentin, and J.-M. Vaugeois
Adenosine A2A receptors and depression
Neurology, December 9, 2003; 61(90116): S82 - 87.
[Abstract] [Full Text]


Home page
NeurologyHome page
Y. Urade, N. Eguchi, W.-M. Qu, M. Sakata, Z.-L. Huang, J.-F. Chen, M. A. Schwarzschild, J. S. Fink, and O. Hayaishi
Minireview: Sleep regulation in adenosine A2A receptor-deficient mice
Neurology, December 9, 2003; 61(90116): S94 - 96.
[Full Text]


Home page
Mol. Pharmacol.Home page
K. Murphy, V. Gerzanich, H. Zhou, S. Ivanova, Y. Dong, G. Hoffman, G. A. West, H. R. Winn, and J. M. Simard
Adenosine-A2a Receptor Down-Regulates Cerebral Smooth Muscle L-Type Ca2+ Channel Activity via Protein Tyrosine Phosphatase, Not cAMP-Dependent Protein Kinase
Mol. Pharmacol., September 1, 2003; 64(3): 640 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Blum, M.-C. Galas, A. Pintor, E. Brouillet, C. Ledent, C. E. Muller, K. Bantubungi, M. Galluzzo, D. Gall, L. Cuvelier, et al.
A Dual Role of Adenosine A2A Receptors in 3-Nitropropionic Acid-Induced Striatal Lesions: Implications for the Neuroprotective Potential of A2A Antagonists
J. Neurosci., June 15, 2003; 23(12): 5361 - 5369.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
U. Aden, L. Halldner, H. Lagercrantz, I. Dalmau, C. Ledent, and B. B. Fredholm
Aggravated Brain Damage After Hypoxic Ischemia in Immature Adenosine A2A Knockout Mice
Stroke, March 1, 2003; 34(3): 739 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Bailey, C. Ledent, M. Kelly, S. M. O. Hourani, and I. Kitchen
Changes in Spinal delta and kappa Opioid Systems in Mice Deficient in the A2A Receptor Gene
J. Neurosci., November 1, 2002; 22(21): 9210 - 9220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. C. Montesinos, A. Desai, J.-F. Chen, H. Yee, M. A. Schwarzschild, J. S. Fink, and B. N. Cronstein
Adenosine Promotes Wound Healing and Mediates Angiogenesis in Response to Tissue Injury Via Occupancy of A2A Receptors
Am. J. Pathol., June 1, 2002; 160(6): 2009 - 2018.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. J. Leibovich, J.-F. Chen, G. Pinhal-Enfield, P. C. Belem, G. Elson, A. Rosania, M. Ramanathan, C. Montesinos, M. Jacobson, M. A. Schwarzschild, et al.
Synergistic Up-Regulation of Vascular Endothelial Growth Factor Expression in Murine Macrophages by Adenosine A2A Receptor Agonists and Endotoxin
Am. J. Pathol., June 1, 2002; 160(6): 2231 - 2244.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
U. Aden, V. Dahlberg, B. B. Fredholm, L.-J. Lai, Z. Chen, and B. Bjelke
MRI Evaluation and Functional Assessment of Brain Injury After Hypoxic Ischemia in Neonatal Mice
Stroke, May 1, 2002; 33(5): 1405 - 1410.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Schwarzschild, J.-F. Chen, and A. Ascherio
Caffeinated clues and the promise of adenosine A2A antagonists in PD
Neurology, April 23, 2002; 58(8): 1154 - 1160.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Popoli, A. Pintor, M. R. Domenici, C. Frank, M. T. Tebano, A. Pezzola, L. Scarchilli, D. Quarta, R. Reggio, F. Malchiodi-Albedi, et al.
Blockade of Striatal Adenosine A2A Receptor Reduces, through a Presynaptic Mechanism, Quinolinic Acid-Induced Excitotoxicity: Possible Relevance to Neuroprotective Interventions in Neurodegenerative Diseases of the Striatum
J. Neurosci., March 1, 2002; 22(5): 1967 - 1975.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. M. Sebastiao, A. de Mendonca, T. Moreira, and J. A. Ribeiro
Activation of Synaptic NMDA Receptors by Action Potential-Dependent Release of Transmitter during Hypoxia Impairs Recovery of Synaptic Transmission on Reoxygenation
J. Neurosci., November 1, 2001; 21(21): 8564 - 8571.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-F. Chen, R. Moratalla, F. Impagnatiello, D. K. Grandy, B. Cuellar, M. Rubinstein, M. A. Beilstein, E. Hackett, J. S. Fink, M. J. Low, et al.
The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice
PNAS, February 13, 2001; 98(4): 1970 - 1975.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Majid, Y. Y. He, J. M. Gidday, S. S. Kaplan, E. R. Gonzales, T. S. Park, J. D. Fenstermacher, L. Wei, D. W. Choi, C. Y. Hsu, et al.
Differences in Vulnerability to Permanent Focal Cerebral Ischemia Among 3 Common Mouse Strains Editorial Comment
Stroke, November 1, 2000; 31(11): 2707 - 2714.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. HASKÓ, D. G. KUHEL, J.-F. CHEN, M. A. SCHWARZSCHILD, E. A. DEITCH, J. G. MABLEY, A. MARTON, and C. SZABÓ
Adenosine inhibits IL-12 and TNF-{alpha} production via adenosine A2a receptor-dependent and independent mechanisms
FASEB J, October 1, 2000; 14(13): 2065 - 2074.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J.-F. Chen, K. Xu, J. P. Petzer, R. Staal, Y.-H. Xu, M. Beilstein, P. K. Sonsalla, K. Castagnoli, N. Castagnoli Jr, and M. A. Schwarzschild
Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease
J. Neurosci., May 15, 2001; 21(10): RC143 - RC143.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-